Copyright
©The Author(s) 2025.
World J Clin Oncol. Feb 24, 2025; 16(2): 99839
Published online Feb 24, 2025. doi: 10.5306/wjco.v16.i2.99839
Published online Feb 24, 2025. doi: 10.5306/wjco.v16.i2.99839
Figure 8 Correlation analysis between drug sensitivity of tumour targeted therapy drugs and proteasome 26S subunit non-ATPase 6 mRNA expression level in hepatocellular carcinoma tissues.
PSMD6: Proteasome 26S subunit non-ATPase 6.
- Citation: Zhou SS, Ye YP, Chen Y, Zeng DT, Zheng GC, He RQ, Chi BT, Wang L, Lin Q, Su QY, Dang YW, Chen G, Wei JL. Overexpression pattern, function, and clinical value of proteasome 26S subunit non-ATPase 6 in hepatocellular carcinoma. World J Clin Oncol 2025; 16(2): 99839
- URL: https://www.wjgnet.com/2218-4333/full/v16/i2/99839.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i2.99839